Rapid Micro Biosystems Inc (RPID)

Currency in USD
1.7000
+0.0100(+0.59%)
Closed·
1.7900+0.0900(+5.29%)
·
Advertisement
Unusual Pre-Market activity
RPID is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.66001.7350
52 wk Range
1.58004.9400
Key Statistics
Prev. Close
1.7
Open
1.7
Day's Range
1.66-1.735
52 wk Range
1.58-4.94
Volume
89K
Average Volume (3m)
207.9K
1-Year Change
-39.7163%
Book Value / Share
0.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RPID Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.6667
Upside
+292.16%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Rapid Micro Biosystems Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.6667
(+292.16% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stifel
Buy8.00+370.59%-Maintain10/08/2026
Lake Street
Buy7.00+311.76%8.00Maintain22/05/2026
Stifel
Buy8.00+370.59%8.00Maintain14/05/2026
Stifel
Buy8.00+370.59%-Maintain16/03/2026

Rapid Micro Biosystems Inc Earnings Call Summary for Q2/2026

  • Rapid Micro reported Q2 revenue of $8.1M, up 11% YoY and beating $7.85M forecast; gross margin surged to 15% from 4% prior year.
  • Consumable revenue grew over 20% YoY to record levels; company completed 9 validations and raised full-year validation guidance to at least 27 systems.
  • Full-year 2026 revenue guidance reaffirmed at $37M-$41M; Q3 revenue expected at minimum $9.5M with gross margin reaching at least 20%.
  • Net loss widened to $12.9M from $11.9M; management projects lower H2 cash burn aided by $1M efficiency program saving $3M annually from 2027.
  • Stock fell 1.46% in premarket to $2.05 despite revenue beat, as investors focused on continued losses and $20M cash position amid ongoing burn rate.
Last Updated: 07/08/2026, 14:24
Read Full Transcript

Earnings

Latest Release
07/08/2026
EPS / Forecast
-0.27 / -0.25
Revenue / Forecast
8.05M / 7.85M
EPS Revisions
Last 90 days

Compare RPID to Peers and Sector

Metrics to compare
RPID
Peers
Sector
Relationship
P/E Ratio
−1.7x−1.1x−0.4x
PEG Ratio
0.140.000.00
Price/Book
4.8x6.5x2.6x
Price / LTM Sales
2.4x4.5x3.1x
Upside (Analyst Target)
314.2%18.0%48.4%
Fair Value Upside
Unlock−7.9%6.5%Unlock

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.75M3.54%2.95M
Other Institutional Investors
32.76M66.29%55.36M
Public Companies & Retail Investors
14.91M30.17%25.20M
Total
49.42M100.00%83.52M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bain Capital Life Sciences Fund, L.P.15.48%7,651,36912,931
Bain Capital Life Sciences Investors, LLC15.48%7,651,36912,931

People Also Watch

28.49
CLMB
+0.81%
23.15
MATW
-0.43%
15.79
NWBI
+0.45%
0.8824
ONCO
-1.03%

FAQ

What Is the Rapid Micro Biosystems (NASDAQ: RPID) Share Price Today?

The Rapid Micro Biosystems stock price today is 1.7000 USD.

What Stock Exchange Does Rapid Micro Biosystems (RPID) Trade On?

Rapid Micro Biosystems is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Rapid Micro Biosystems?

The stock symbol (also called a 'ticker') for Rapid Micro Biosystems is "RPID."

What Is the Current Rapid Micro Biosystems Market Capitalisation?

As of today, Rapid Micro Biosystems (NASDAQ: RPID) market cap is 85.2700M USD.

What Is Rapid Micro Biosystems's (RPID) Earnings Per Share (TTM)?

The Rapid Micro Biosystems EPS is currently -1.1155 (Trailing Twelve Months).

When Is the Next Rapid Micro Biosystems Earnings Date?

Rapid Micro Biosystems's next earnings report will be released on 05/11/2026.

Is RPID a Buy or Sell From a Technical Analyst Perspective?

Based on today's Rapid Micro Biosystems moving averages and other technical indicators, the daily buy/sell signal for RPID stock is Strong Sell.

How Many Times Has Rapid Micro Biosystems Stock Split?

Rapid Micro Biosystems has split 0 times. (See the RPID stock split history page for full effective split date and price information.)

How Many Employees Does Rapid Micro Biosystems Have?

Rapid Micro Biosystems has 171 employees, based on their latest Companies House report.

What is the current trading status of Rapid Micro Biosystems (NASDAQ: RPID)?

As of 14/08/2026, Rapid Micro Biosystems (RPID) is trading at a share price of 1.7000 USD, with a previous close of 1.7000 USD. The stock has fluctuated within a day range of 1.6600 USD to 1.7350 USD, while its 52-week range spans from 1.5800 USD to 4.9400 USD.

What Is Rapid Micro Biosystems (RPID) Price Target According to Analysts?

The average 12-month price target for Rapid Micro Biosystems is 6.6667 USD, with a high estimate of 8 USD and a low estimate of 5 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +292.16% Upside potential.

What Is the RPID Premarket Price?

RPID's last pre-market stock price is 1.7900 USD. The pre-market share volume is 20,140.0000, and the stock has decreased by 0.0900, or 5.2900%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.